SCIENTIFIC DEVICES DEVELOPMENT

Brand Owner (click to sort) Address Description
A Accentia, Inc. 324 S. Hyde Park Avenue Suite 350 Tampa FL 33606 Scientific devices for the development, production and proliferation of cells and proteins, namely bioreactors for automated cell culture and protein production; automated protein purification systems comprising filtration cassettes, filtration membranes, filtration modules, columns, chromatography columns, resin packed columns, ion exchange columns, purification monitors, ultraviolet monitors, photometers, valves, tubing, reservoirs, liquid reservoirs, cell culture media reservoirs and collection vessels; replacement parts for bioreactors and purification systems including filtration cassettes, filtration membranes, filtration modules, columns, chromatography columns, resin packed columns, ion exchange columns, purification monitors, ultraviolet monitors, photometers, gas exchange cartridges, cell culture cartridges, incubation chambers, pumps, culture chambers, valves, tubing, reservoirs, liquid reservoirs, cell culture media reservoirs and collection vessels; and control systems for use with bioreactors and purification systems, namely, microprocessors, process control computers, culture monitors, purification monitors, electronic data recorders, ultraviolet monitors and photometers;Pharmaceutical preparations, proteins, antibodies, vaccine compositions, antifungals, antitussives, decongestants, cell based products, namely coagulation factors and immune stimulants, and growth factors, namely cytokines, hormones, morphogens and interleukins for use in the diagnosis, cure, mitigation, treatment and prevention of diseases and conditions, namely sinus infections, asthma, sinus inflammation, chronic rhinosinusitis, allergic fungal rhinosinusitis, cancers, lymphomas, Non-Hodgkins lymphoma, B-cell Non-Hodgkins lymphoma, diseases of the immune system, tissue repair and tissue growth applications, allergies, cough, cold, inflammation, fever, nausea and vomiting; and pharmaceutical preparations for the treatment and mitigation of pain;ACCENTIA;Color is not claimed as a feature of the mark.;Business consultation in the field of pharmaceutical commercialization; distributorship in the field of pharmaceutical product;Drug delivery systems;Pharmaceutical drug development services;
ACCENTIA BIOPHARMACEUTICALS Accentia Biopharmaceuticals, Inc. 324 S. Hyde Park Ave., Suite 350 Tampa FL 33606 Scientific devices for the development, production and proliferation of cells and proteins not for use with diabetes associated conditions, namely bioreactors for automated cell culture and protein production; automated protein purification systems comprising filtration cassettes, filtration membranes, filtration modules, columns, chromatography columns, resin packed columns, ion exchange columns, purification monitors, ultraviolet monitors, photometers, valves, tubing, reservoirs, liquid reservoirs, cell culture media reservoirs and collection vessels; cultureware and replacement parts for bioreactors and purification systems including filtration cassettes, filtration membranes, filtration modules, columns, chromatography columns, resin packed columns, ion exchange columns, purification monitors, ultraviolet monitors, photometers, gas exchange cartridges, cell culture cartridges, incubation chambers, pumps, culture chambers, valves, tubing, reservoirs, liquid reservoirs, cell culture media reservoirs and collection vessels; and control systems for use with bioreactors and purification systems namely microprocessors, process control computers, culture monitors, purification monitors, electronic data recorders, ultraviolet monitors and photometers;Biologic product preparations, namely proteins, antibodies, vaccine compositions, antifungals, antitussives, decongestants, cell based products, namely coagulation factors and immune stimulants, and growth factors, namely cytokines, hormones, morphogens and interleukins for use in the diagnosis, cure, mitigation, treatment and prevention of diseases and conditions not associated with diabetes, namely sinus infections, asthma, sinus inflammation, chronic rhinosinusitis, allergic fungal rhinosinusitis, cancers, lymphomas, Non-Hodgkins lymphoma, B-cell Non-Hodgkins lymphoma, diseases of the immune system, tissue repair and tissue growth applications, allergies, cough, cold, inflammation, fever, nausea and vomiting; and pharmaceutical preparations for the treatment and mitigation of pain;ACCENTIA BIO PHARMACEUTICALS;Business consultation in the field of commercialization of pharmaceuticals not for use with diabetes associated conditions; distributorship in the field of pharmaceutical products not for use with diabetes associated conditions;Drug delivery systems for diseases and conditions not associated with diabetes;BIOPHARMACEUTICALS;Pharmaceutical drug development services not associated with diabetes;
BIOVEST BIOVEST INTERNATIONAL, INC. 324 S. Hyde Park Ave. Suite 350 Tampa FL 33606 Scientific devices for the development, production and proliferation of proteins, namely, bioreactors for automated cell culture and protein production, automated protein purification systems, culture ware consisting of disposable inserts for said bioreactors and purification systems; replacement parts for said bioreactors and purification systems; and control systems for use with said bioreactors and purification systems;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. An image forming apparatus includes an electrostatic latent image carrier. A plurality of development units each accommodate a toner and are held by a development unit holder. A control unit controls the development unit holder and selectively changes over the development unit used in development. An identifying device identifies color information on the toner. The development unit holder holds at least two development units accommodating toner of a same color. The control unit identifies development units of the same color based on the color information identified by the identifying device, and controls the development unit holder to effect monochrome development by using the at least two development units.